Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Due to production issues
| Brand name | SODIUM IODIDE I-131 |
| Generic name | SODIUM IODIDE I-131 |
| Distributed by / for | Radnostix |
| NDC | 69208-003-15 |
| Full product label | Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID. |
| Recalling firm | Radnostix |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 16 units |
| Recall initiated | 2026-01-26 |
| Report date | 2026-03-11 |
| Recall completed | — |
| Recall number | D-0389-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Idaho Falls ID United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗